Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

scientific article

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2017/9642027
P932PMC publication ID5406716
P698PubMed publication ID28487769

P50authorMelvin H SeidQ88026358
P2093author name stringAshwin Chatwani
Angelia D Butcher
P2860cites workA multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemiaQ38314781
How we diagnose and treat iron deficiency anemiaQ38593099
The safety of intravenous iron dextran in hemodialysis patientsQ40926289
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trialQ43291667
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.Q45911764
Update on adverse drug events associated with parenteral ironQ46212164
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemiaQ46782839
High prevalence of postpartum anemia among low-income women in the United StatesQ74415587
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trialQ80710282
Treatment for women with postpartum iron deficiency anaemiaQ24187876
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisQ26822051
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trialQ34014222
Iron deficiency anemia in women across the life spanQ34315499
Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltoseQ34700903
Safety in iron managementQ35140921
Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicityQ35141918
FGF-23: More than a regulator of renal phosphate handling?Q35156017
Iron Deficiency and Erythropoiesis: New Diagnostic ApproachesQ35538677
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled TrialsQ36241297
Management of Iron Deficiency AnemiaQ36812538
Ferric carboxymaltose: a review of its use in iron-deficiency anaemiaQ37465214
A systematic analysis of global anemia burden from 1990 to 2010.Q37535215
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)9642027
P577publication date2017-04-13
P1433published inAnemiaQ26842521
P1476titleFerric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
P478volume2017

Reverse relations

cites work (P2860)
Q90435077Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study
Q88035892Ferric Carboxymaltose: A Review in Iron Deficiency
Q92060061Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review